138 results
Page 4 of 7
8-K
EX-99.1
cx7f16wyjx1kd 9kfms
23 Mar 20
Intra-Cellular Therapies Announces Availability of CAPLYTA™ (lumateperone) for Adult Patients with Schizophrenia
7:52am
8-K
EX-99.1
m60ia
2 Mar 20
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2019 Financial Results and Provides Corporate Update
7:43am
8-K
EX-1.1
bn97a
8 Jan 20
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-99.1
fezy33
23 Dec 19
FDA Approves Intra-Cellular Therapies’ Novel Antipsychotic, CAPLYTA® (lumateperone) for the Treatment of Schizophrenia in Adults
8:15am
8-K
EX-99.1
osnzy 4rhwekd67z1
5 Nov 19
Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2019 Financial Results
7:40am
DEFA14A
d88o05chlzmwz17u 639
14 Jun 19
Additional proxy soliciting materials
4:31pm
8-K
EX-99.1
sdbzuz tevmq
8 May 19
Intra-cellular Therapies Reports First Quarter 2019 Financial Results and Provides Corporate Update
7:35am
8-K
EX-99.1
v321ckdjuck05uzos0s
27 Feb 19
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2018 Financial Results and Provides Corporate Update
7:43am
8-K
sf54edezefk wq
12 Dec 18
Other Events
7:02am
8-K
EX-99.1
jn8syf 8rlw
12 Dec 18
Other Events
7:02am
8-K
EX-99.1
ojbqx6q
7 Nov 18
Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2018 Financial Results
7:17am